or Try an Advanced Search...

    Mesoblast Stocks List

    Symbol Grade Name % Change
    MESO B Mesoblast Limited -1.94
    CARA D Cara Therapeutics, Inc. -0.61
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Acute And Chronic Pain Adult Stem Cell Amines Back Pain Biopharmaceutical Biotechnology Bone Bone Marrow Cardiovascular Disease Cell Product Chronic Pain Clinical Trial Congestive Heart Failure Degenerative Disc Disease Diabetic Nephropathy Graft Versus Host Disease Heart Failure Hematology Host Disease Inflammatory Conditions

    Related ETFs - A few ETFs which own one or more of the above listed Mesoblast stocks.

    Symbol Grade Name Weight
    CNBS F Amplify Seymour Cannabis ETF 0.09
    FESM B Fidelity Enhanced Small Cap ETF 0.01
    VTI A Vanguard Total Stock Market ETF 0.0
    VXF B Vanguard Extended Market ETF 0.0
    VHT D Vanguard Health Care ETF 0.0
    View all Mesoblast ETFs...
    Compare ETFs
    Compare CNBS to VTI Compare FESM to VHT Compare VTI to VHT

        Mesoblast Stocks Recent News

        Date Stock Title
        Nov 17 CARA Cara Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 CARA Cara: Q3 Earnings Snapshot
        Related Industries: Biotechnology
        Related Stock Lists: Acute And Chronic Pain Adult Stem Cell Amines Back Pain Biopharmaceutical Biotechnology Bone Bone Marrow Cardiovascular Disease Cell Product Chronic Pain Clinical Trial Congestive Heart Failure Degenerative Disc Disease Diabetic Nephropathy Graft Versus Host Disease Heart Failure Hematology Host Disease Inflammatory Conditions
        Mesoblast

        Mesoblast Limited is an Australian-based regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

        More about Mesoblast
        Browse All Tags